<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: The number of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> survivors is increasing, and patients with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> often experience long-lasting consequences of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and its treatment </plain></SENT>
<SENT sid="1" pm="."><plain>Because of the variety of health problems and high prevalence of comorbidity, primary care physicians (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCPs</z:e>) seem obvious candidates to take care of these patients, and insight into primary health care (PHC) use of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> survivors is needed </plain></SENT>
<SENT sid="2" pm="."><plain>We aimed to find determinants for PHC use in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> survivors </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Using data from the Netherlands Information Network of Primary Care, we determined the volume of PHC use in 1,256 adult patients with <z:hpo ids='HP_0003002'>breast cancer</z:hpo>, 503 patients with <z:hpo ids='HP_0012125'>prostate cancer</z:hpo>, and 487 patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> 2 to 5 years after diagnosis and compared this with age- and sex-matched controls without <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> from the same practice </plain></SENT>
<SENT sid="4" pm="."><plain>We also examined whether age, comorbidity, and time since diagnosis were related to PHC use </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The mean annual number of primary care contacts was increased compared with control patients by 24% in patients with <z:hpo ids='HP_0003002'>breast cancer</z:hpo> (P&lt;.001) and by 33% in patients with <z:hpo ids='HP_0012125'>prostate cancer</z:hpo> (P&lt;.001) </plain></SENT>
<SENT sid="6" pm="."><plain>This difference remained constant between 2 and 5 years after diagnosis </plain></SENT>
<SENT sid="7" pm="."><plain>In patients with <z:hpo ids='HP_0003003'>colon cancer</z:hpo>, the difference with controls tended to decrease with age (12% per 10 years; P=.005) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: PHC use is significantly increased 2 to 5 years after diagnosis of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, especially in younger patients without a <z:hpo ids='HP_0011010'>chronic</z:hpo> disease </plain></SENT>
<SENT sid="9" pm="."><plain>Given the expected increase in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> survivors, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCPs</z:e> should prepare themselves for this increasing amount of aftercare </plain></SENT>
<SENT sid="10" pm="."><plain>The development of multidisciplinary care standards for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> survivors could be helpful </plain></SENT>
</text></document>